Background/Aims: Acute lung injury (ALI) is induced by a variety of external and internal factors and leads to acute progressive respiratory failure. Previous studies have shown that apelin-13 can decrease the acute lung injury induced by LPS, but the specific mechanism is unclear. Therefore, a mouse lung injury model and a cell model were designed to explore the mechanism of how apelin-13 alleviates the acute lung injury caused by LPS. Methods: The effect of apelin-13 on LPS-induced structural damage was determined by H&E staining and by the wet/dry weight ratio. The related inflammatory factors in BALF were examined by ELISA. The apoptotic pathway and the NF-κB and NLRP3 inflammasome pathways were evaluated by using Western blotting and immunofluorescence staining. Results: LPS induced the structural damage and the production of inflammatory cytokines in the lung tissues of mice. These deleterious effects were attenuated by apelin-13 administration. The protective effects of apelin-13 were associated with decreased reactive oxygen species (ROS) formation and the inhibition of the activation of the NF-κB and NLRP3 inflammasome pathways in mice and in Raw264.7 cells. Conclusion: Taken together, these data suggest that apelin-13 administration ameliorates LPS-induced acute lung injury by suppressing ROS formation, as well as by inhibiting the NF-κB pathway and the activation of the NLRP3 inflammasome in the lungs.
Apelin-13 Administration Protects

Bronchoalveolar lavage fluid (BAL fluid)
Bronchoalveolar lavage fluid was taken 6 hours after LPS administration. The mice in each group were anesthetized with an intraperitoneal injection of 5% chloral hydrate, and the thoracic cavity was exposed. Then, 0.8 ml of pre-cooled sterile PBS buffer was injected slowly through the total bronchial system into the lungs, resulting in a visual bulge in the lungs, and this pumping of buffer was repeated three times. The extracted lavage fluid was collected in an EP tube and was stored temporarily in the refrigerator at 4°C. The bronchoalveolar lavage fluid was centrifuged at 1, 500 r/min for 10 min. The supernatant was stored at -80°C, and the sediment was suspended in 1% BSA and placed on adhesive slides for immunofluorescence staining.
Histology
Biopsies of the lungs were fixed with 4% paraformaldehyde, were dehydrated, and were then embedded in paraffin. For the histological examination, the lung tissue samples were cut into 5 μm sections and were placed on glass slides. After deparaffinization and dehydration, the tissue samples were stained with hematoxylin and eosin (H&E). The stained slides were analyzed with a light microscope (Axio Imager M1, Karl Zeiss, Goettingen, Germany) under identical conditions. The sections were examined at 200× magnification for all the groups.
Measurement of lung wet/dry weight ratio
The lung wet/dry weight ratio was used to measure the water content in the lung tissue. Each lung was weighed before and after being dried in an 80°C oven for at least 24 hours until the weight was constant. The lung wet/dry ratio was calculated by dividing the wet weight by the dry weight of each lung.
Enzyme-linked immunosorbent assay (ELISA)
The expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6 in the BAL fluid was measured using ELISA kits (e Bioscience Co., Ltd., CA, USA) according to the manufacturer's instructions.
The levels were calculated using standard curves.
Protein concentration in the BAL fluid
The protein concentration in the BAL fluid supernatants was assessed using the BCA protein assay kit (Bio-Rad Laboratories). The measurement of the absorbance at 570 nm was performed with a microplate reader (Infinite 200, Tecan Group, Switzerland).
ROS determination
Reactive oxygen species (ROS) accumulation in the lungs was examined by dihydroethidium (DHE) staining. Cryostat lung sections were incubated with 5 μmol/L DHE (Molecular Probes, Eugene, OR) for 30 min at 37°C in the dark. The samples were then observed, and images were captured on a Nikon ECLIPSE Ti microscope (Nikon, Tokyo, Japan).
Measurement of tissue and cell mitochondrial ROS production
The mitochondria were isolated from tissue and cells using a mitochondria isolation kit (Wanleibio, China) following the manufacturer's instructions. The ROS production in the mitochondria was detected using the ROS-specific fluorescent probe DCFH-DA. The samples were incubated with 1 mM DCFH-DA at 37°C for 30 min. The fluorescence intensity was measured at 500 nm (excitation) and 525 nm (emission) using a fluorescence microplate reader.
Western Blotting
For the protein extractions, lung tissue or Raw264.7 cells were harvested and lysed in a protein extraction reagent (Pierce, Thermo Scientific) with a cocktail (Roche Life Science, Indianapolis, IN). The extractions of nuclear and cytoplasmic proteins from the lungs or cells were performed with nuclear and cytoplasmic protein extraction reagent kits (Beyotime Institute of Biotechnology). Protein concentrations Cellular Physiology and Biochemistry
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were determined using a BCA protein assay kit (Bio-Rad Laboratories). Equal amounts of protein from the samples were separated by SDS-PAGE on 10% or 12% denaturing gels at 120 V and were transferred onto polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories) at 300 mA for 90 min by the wet transfer method. The membranes were blocked in tris-buffered saline containing 5% skim milk for 2 h at room temperature. After three washes with 0.1% Tween-20 (TBST), the membranes were incubated with the specific primary antibodies against Bcl-2 (ab196495, 1:500-1:2, 000, abcam, USA), Bax (ab32503, 1:1, 000-1:10, 000, abcam, USA), Caspase-3 (#9664, 1:1, 000, CST, USA), I-κB (#4814S, 1:1, 000, CST, USA), p-IκB (#2859, 1:1, 000, CST, USA), NF-κB (SAB4502617, 1:500-1:1000, Sigma, USA), LaminB (ab16048, 1:1, 000, abcam, USA), NLRP3 (#15101, 1:1, 000, CST, USA), Caspase-1 (#2225, 1:1, 000, CST, USA), or IL-1β (#12426, 1:1, 000, CST, USA) overnight at 4°C. Following washing, the membranes were incubated with the relevant secondary antibodies (1:5, 000; Sigma) for 1 h at room temperature. The relative intensities of the bands were analyzed using an image analysis software program (ImageJ 1.44p, Wayne Rasband, National
Institutes of Health, USA).
Immunofluorescence staining
Immunofluorescence staining was performed as described previously [31] . Briefly, 5 μm slices of the paraffin embedded sections of the lung tissue were prepared and baked in a 60°C constant-temperature oven for 60-120 min. After deparaffinization, antigen retrieval and serum blocking, the tissue samples were incubated with primary antibodies against NF-κB (Sigma, 1:200) or F4/80 (Abcam, 1:200) at 4°C overnight and were then incubated with the relevant secondary antibodies for 1 h at room temperature. The nuclei were stained with DAPI fluorescent dye for 5 min. All the images were captured on a Nikon ECLIPSE Ti microscope (Nikon, Tokyo, Japan), and the sections were examined at 400× magnification for all the groups.
Cell culture and reagents
The Raw264.7 cell line was purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). The cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) (GIBCO, USA), 100 IU/ml penicillin and 100 µg/ml streptomycin at 37°C with 5% CO 2 in air. Apelin-13 was dissolved in sterile saline at a concentration of 1 μmol/L and was carefully placed in each well with the prepared cells 1 hour before LPS treatment.
CCK8 cell proliferation assay
Raw264.7 cells were cultured in 96-well plates at a density of 1× 10 4 cells per well and were allowed to attach overnight. Cells were treated with LPS (0.05, 0.1, 0.5, 1, 5 and 10 μg/ml) for 24hr or 1 µg/ml LPS for different times (0, 3, 6, 12 and 24hr). Different concentration of apelin (0.1, 0.5, 1μmol/L) was added to Raw264.7 cells before LPS. Then volume of 10 μl Cell Counting Kit-8 solution (CCK8; Dojindo Laboratories, Japan) was added to each well, followed by 2 h of incubation. The absorbance of each well was measured at 450 nm using an automatic multiwell spectrophotometer.
Measurement of the mitochondrial membrane potential (ΔΨm)
The ΔΨm of the Raw264.7 cells was determined using the mitochondrial membrane potential assay kit with JC-1 (Beyotime, China). Briefly, Raw264.7 cells with different treatments were incubated with 10 μg/ ml JC-1 for 20 min at 37 °C and were then washed with washing buffer two times. All the images were captured on a Nikon ECLIPSE Ti microscope (Nikon, Tokyo, Japan).
Statistical analysis
The data are presented as the means ± SEM. The results for the animal experiments are representative of at least 3 independent experiments. Student's t-test was used for the statistical analysis of comparisons between two groups. For more than two groups, evaluation of the data was performed using a one-way analysis-of-variance (ANOVA) test, followed by Tukey's post-hoc test. P values <0.05 were accepted as statistically significant.
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Results
Apelin-13 decreases the structural damage and the production of inflammatory mediators in an LPS-induced lung injury mouse model
To determine whether apelin-13 could protect against LPS-induced ALI, the histopathologic features of the lungs from the different groups were evaluated by light microscopy. Histological analyses showed marked infiltration of inflammatory cells into the alveolar space, peribronchial wall thickening, and vascular congestion in the lungs of the LPS-induced treated mice. These histologic changes were dramatically reduced by administration of apelin (Fig. 1A) . To evaluate changes in lung edema, lung wet/dry weight ratios were measured. As shown in Fig. 1B , a notable increase in the lung wet/dry weight ratio was caused by LPS instillation compared with the control group (p<0.05). The wet/dry weight ratio was markedly attenuated by administration of apelin (p<0.05). A change in the total protein concentration in BALF is a characteristic of increased capillary permeability. A sharp increase in total protein in the BALF was observed in the LPS group (p<0.01), which was significantly blocked by apelin pretreatment (p<0.01) (Fig. 1C) . Furthermore, the expression levels of the inflammatory factors TNF-a, IL-6 and IL-1β in the BAL fluid of the different groups were also measured by ELISA. Compared to the control group, the mice treated with LPS had significantly increased levels of the cytokines TNF-a (Fig. 1D, p<0 .01), IL-6 (Fig. 1E , p<0.01) and IL-1β (Fig. 1F, p<0 .01) in the BAL fluid, and administration of apelin-13 clearly attenuated these LPS-induced increases (p < 0.05 ~ p < 0.01). These results illustrated that administration of apelin-13 could alleviate LPS-induced lung injury in mice.
Apelin-13 decreases reactive oxygen species (ROS) generation and mitochondrial apoptosis in LPS-induced mice
To further evaluate the effects of apelin-13 on LPS-induced lung injury, the generation of reactive oxygen species in mice was assessed by DHE staining. As shown in Fig. 2A , stimulation with LPS significantly increased the ROS generation in the mouse lungs, which was largely reduced by apelin-13. We found consistent results in mitochondrial ROS production (Fig. 2B) . Furthermore, the protein expression levels of B-cell lymphoma 2 (Bcl-2), Bcl-2 X-associated protein (Bax) and cleaved caspase-3 were measured by Western blotting. Our results showed that LPS significantly increased the expression levels of Bax and cleaved caspase-3 (p < 0.01) and decreased the expression level of Bcl-2 (p < 0.05). These effects were markedly reversed by treatment with apelin ( Fig. 2C -E, p < 0.05 ~ p < 0.01). These results indicated that apelin-13 alleviated oxidative stress and mitochondria-mediated cell apoptosis induced by LPS in mice.
Apelin-13 prevents the nuclear translocation of NF-κB in LPS-treated mice
To assess the effects of apelin-13 on the NF-κB inflammatory pathway, the expression of classic IκB/NF-κB pathway proteins were measured in vivo by Western blotting. As shown in Fig. 3A and 3B , the cytosolic level of p-IκBα was rapidly activated in mice treated with LPS for 6 h (p<0.01), and LPS administration caused the nuclear translocation of NF-κB p65 in the injured lungs of mice with ALI (p<0.01). Both of these phenotypes were significantly inhibited by pretreatment with apelin-13 (p<0.05~ p<0.01). Furthermore, we investigated whether macrophages could be involved in ALI induced by LPS using immunofluorescence staining for F4/80 (a mouse macrophage-specific marker). As shown in Fig. 3C , LPS injection enhanced F4/80 immunoreactivity in the lung tissue, indicating increased macrophages infiltration; however, apelin-13 administration markedly reduced macrophage infiltration. These results indicated that apelin-13 inhibited the nuclear translocation of NF-κB p65 and the macrophage infiltration induced by LPS in mice.
Apelin-13 inhibits the NLRP3 inflammasome inflammatory pathway in LPS-treated mice
To assess the effects of apelin on LPS-induced NLRP3 inflammasome activation, the expression of the inflammatory cytokines NLRP3, caspase-1 and IL-1β were examined in
the different groups by Western blotting. The results showed that the expression levels of NLRP3 (Fig. 4A, p<0.01 ), cleaved caspase-1 (Fig. 4B, p<0 .05) and IL-1β (Fig. 4C, p<0 .01) were significantly increased in the LPS group compared with the control group, while apelin-13 markedly reduced the expression of all three inflammatory cytokines (Fig. 3E, p<0 .05~ p<0.01). These results indicated that apelin-13 inhibited the activation of the NLRP3 inflammasome induced by LPS in lung tissue.
Apelin-13 protects Raw264.7 cells from injury induced by LPS
To mimic LPS-induced lung injury, the effects of LPS on the viability of Raw264.7 cells was determined using the CCK8 assay. As shown in Fig. 5 , treatment of the cells with LPS at 0.05, 0.1 and 0.5 μg/ml did not affect cell viability (p > 0.05) (Fig. 5A) , whereas cell viability was significantly decreased after treatment with LPS at concentrations of 1, 5 and 10 μg/ml (p<0.05~ p<0.01). At the same time, treatment of the cells with 1 μg/ml of LPS resulted in obvious decreases in cell viability at 6, 12 and 24 h (Fig. 5B) . Therefore, we chose 1 μg/ml LPS for 6 h for further experiments. The CCK8 assay also showed that the decrease in viability after 6 h of LPS stimulation was rescued in the cells pre-treated with 1μmol/L apelin-13 (p< 0.05). Apelin-13 alone had no significant effect on cell viability (Fig. 5C) . Therefore, 1μmol/L apelin-13 was chose for following experiments. To explore the possible mechanism involved in the reversal of acute lung injury, the levels of apoptosis in Raw264.7 cells were determined by Western blotting, and the effect of apelin-13 on the mitochondrial membrane potential was detected by JC-1 staining. As shown in Fig. 5D , LPS significantly induced the loss of mitochondrial membrane potential, which was markedly reversed by treatment with apelin-13. Mitochondrial dysfunction may trigger the release of large amounts of ROS. Our results demonstrated that apelin blocked the increase in ROS levels induced by LPS (Fig.  5E, p<0.01) . Furthermore, we evaluated the activation status of Bcl-2, Bax and cleaved caspase-3. As shown in Fig. 5F -H, LPS markedly increased the expression levels of Bax (p<0.01) and cleaved caspase-3 (p<0.01) and decreased the level of Bcl-2 (p<0.01), and these changes were significantly reversed by apelin (p<0.05~p<0.01). These results indicated that apelin-13 inhibited the cell injury and apoptosis induced by LPS in Raw264.7 cells.
Apelin-13 attenuates the nuclear translocation of NF-κB p65 induced by LPS in Raw264.7 cells
The effects of apelin-13 on NF-κB activation on LPS-induced Raw264.7 cell injury was further investigated. The expression levels of proteins in the classic NF-κB pathway in Raw264.7 cells were examined. The results of Western blotting and immunofluorescence staining indicated that compared with the control group, the levels of p-IκB and nuclearlocalized NF-κB p65 clearly increased after LPS administration in Raw264.7 cells (p< 0.01). However, pretreatment with apelin-13 clearly blocked the increased expression of p-IκB and the nuclear translocation of NF-κB p65 induced by LPS (p< 0.01) (Fig. 6A-C) . These results indicated that apelin-13 inhibited the induction of the NF-κB inflammatory pathway by LPS in Raw264.7 cells.
Apelin-13 inhibits the induction of the NLRP3 inflammatory pathway by LPS in Raw264.7 cells
The expression levels of proteins involved in the NLRP3 inflammatory pathway in Raw264.7 cells were detected by Western blotting. The results showed that LPS treatment significantly increased the levels of NLRP3 (p< 0.01) (Fig. 7A ) and activated caspase-1 (p< 0.01) (Fig. 7B) , as well as contributed to IL-1β maturation (p< 0.05) (Fig. 7C) , and all of these effects were reversed by apelin-13 (p< 0.05~p< 0.01). Moreover, consistent with the Western blotting results, ELISA assays showed that apelin inhibited IL-1β secretion induced by LPS (p< 0.01) (Fig. 7D) . These results indicated that apelin-13 attenuated the injury of LPS-induced Raw264.7 cells by inhibiting the NLRP3 inflammatory pathway. 
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Discussion
Our study provides some new information about the roles of apelin in LPS-induced acute lung injury in vivo and in vitro. Although, in our previous study, we found that apelin restrains lung injury induced by LPS, the underlying molecular mechanisms were not entirely clear. In the present study, we further demonstrated that treatment with apelin reduced LPS-induced oxidative damage, apoptosis and inflammatory responses, providing additional evidence that apelin might serve as a protective drug for LPS-induced acute lung injury.
ALI remains a severe disease that threatens human life around the world and manifests as abnormal gas exchange or chest pain. Despite the development of innovative therapies and intensive care, ALI induced by bacteria or other microbial infection remains an unresolved issue. The peptide apelin is a recently described ligand for the G-protein-coupled receptor APJ (APLNR) [22] . Apelin is closely linked to the occurrence and development of ARDS, pulmonary hypertension, lung cancer and other respiratory diseases [24, 33, 34] . It has been shown that apelin has a positive inotropic effect on normal and injured myocardia in rats [35, 36] . At the same time, the apelin-APJ system has the potential to compensate for cardiac function, and a decrease in its expression and function is a possible reason for the occurrence and development of heart failure [34, 35, 37] . In our previous study, apelin-13 treatment significantly alleviated lung inflammation and injury and improved oxygenation in OA-and LPS-induced lung injury [38] . Our data showed that LPS stimulation significantly induced lung tissue histological changes and increased the expression of inflammatory cytokines and the total protein content in bronchoalveolar lavage fluid, as well as other indicators of change, indicating that these mice showed obvious characteristics of ALI/ARDS. When exogenous apelin-13 was given, the pathological changes and the expression of the inflammatory cytokines TNF-α, IL-6 and IL-1β in the bronchoalveolar lavage fluid significantly decreased. In addition, apelin-13 significantly attenuated lung wet/dry weight ratios and protein leakage in BALF. These findings indicated the potential therapeutic effects of apelin-13. Furthermore, we explored the underlying mechanisms of apelin-13-mediated protection against LPS-induced lung injury.
Oxidative stress characterized by excessive ROS is central to the severe pulmonary inflammation that results in ALI/ARDS [39] . It is reported that apelin can inhibit apoptosis in the ischemic myocardium by up-regulating Bcl-2 expression and by down-regulating Bax and cleaved caspase-3 [40] and that it can also reduce the damage to myocardial cells induced by ischemia reperfusion by activating the PI3k/akt pathway in isolated rat hearts [41] ; it can also prevent reactive oxygen-dependent cardiac hypertrophy [42] . Our results were consistent with previous studies and showed that LPS induced a significant decrease in ΔΨm and an increase in ROS levels in lung tissue, which could be reversed by apelin-13 treatment. Moreover, we demonstrated that LPS clearly up-regulated the levels of the proapoptotic protein Bax and cleaved caspase-3 and down-regulated the level of the antiapoptotic protein Bcl-2 in lung tissue and in Raw264.7 cells and that these effects could be reversed by apelin-13 treatment. Therefore, apelin exerted protective effects by eliminating the ROS and the mitochondria damage induced by LPS stimulation in mice.
Inflammatory cell infiltration and pro-inflammatory cytokine generation are both important characteristics in the process of LPS-induced ALI [43, 44] . ROS generation is a crucial regulator of modifications of inflammatory pathways during acute inflammation of 
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Cellular Physiology and Biochemistry the lungs [45] . It has been reported that LPS treatment can activate ROS and can further stimulate NF-κB signaling, and these results are consistent with our previous studies [6, 46] . In the study of Lu et al., in human umbilical vein endothelial cells, apelin-APJ induced ICAM-1, VCAM-1 and MCP-1 expression via the NF-κB/JNK signaling pathway [47] . In our model, administration of apelin-13 inhibited the classic NF-κB signaling pathway and the activation of NF-κB, and it limited macrophage infiltration induced by LPS in vivo and in Raw264.7 cells. The results also indicated that strict regulation of the activity of NLRP3 inflammatory bodies is an important part of maintaining immune homeostasis. A large number of studies have shown that the activation of the NLRP3 inflammatory body can induce severe autoimmune disease. In vivo evidence also indicated that LPS can activate the NLRP3 inflammasome to induce inflammatory responses by mediating immune cell infiltration and aggravating injury [48, 49] . Apelin inhibits the activation of the NLRP3 inflammasome, attenuates the systemic inflammatory response, ameliorates insulin resistance, and promotes survival after severe burn [31] . In the present study, LPS-induced NLRP3 inflammasome activation and enhanced caspase-1 activity were inhibited by apelin; furthermore, the maturation and release of IL-1β in lung tissues were also suppressed by apelin in mice and in Raw264.7 cells.
Conclusion
In conclusion, the exogenous administration of apelin-13 significantly improved LPSinduced lung injury in mice. A schematic for protective of apelin from LPS-induced lung injury is illustrated in Fig. 7E . Our study implies that apelin-13 may alleviate LPS-induced lung injury by inhibiting oxidative stress damage, cell apoptosis, and NF-κB signaling as well as the NLRP3 inflammasome pathway in vivo and in vitro. The above evidence provides new targets and new ideas for the diagnosis and treatment of acute lung injury and suggests that apelin-13 should be considered as an agent for the treatment of ALI.
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